Optimal reversal dose of Sugammadex in a short post-operative period in adult patients

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2012
INTERVENTION: the group of rising T1 height over 10% after additional dosage of suggamadex the group of rising T1 height not over 10% after additional dosage of suggamadex CONDITION: the patients scheduled for elective surgery requiring general anesthesia PRIMARY OUTCOME: Evaluation of neuromuscular responses with a peripheral neurostimulator INCLUSION CRITERIA: the patients scheduled for elective surgery requiring general anesthesia. the patients were ASA physical status 1‐2.
Epistemonikos ID: 45b6d2973e9df27bafb59d3cc648c9515d470a97
First added on: Aug 22, 2024